Cho-Han Chiang

21PUBLICATIONS
56CO-AUTHORS
Cancer geneticsHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Dec 08, 2025
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.

Albert Ko, Yu-Cheng Chang, Furkan Bahar

|Aug 22, 2025
Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism.

Sirui Ma, Yu-Cheng Chang, Cho-Han Chiang

|Feb 05, 2025
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulation.

Cho-Han Chiang, Junmin Song, Yu-Cheng Chang

|Jan 21, 2025
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study.

Furkan Bahar, Betul Ibis, Sena Cakir Colak

|Nov 07, 2024
Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma.

Yu Jen Alexander Jan, Cho-Han Chiang, Soravis Osataphan

|Sep 16, 2024
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?

Jia Yi Tan, Yong Hao Yeo, Wern Lynn Ng

Pageof 4

Frequent Collaborators

5 joint publications

Cho-Hung Chiang

3 joint publications

Junmin Song

3 joint publications

Rushad Patell

2 joint publications

Soravis Osataphan